1. Home
  2. VRAX vs SLE Comparison

VRAX vs SLE Comparison

Compare VRAX & SLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • SLE
  • Stock Information
  • Founded
  • VRAX 2013
  • SLE 2014
  • Country
  • VRAX United Kingdom
  • SLE United States
  • Employees
  • VRAX N/A
  • SLE N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • SLE Services-Misc. Amusement & Recreation
  • Sector
  • VRAX Health Care
  • SLE Consumer Discretionary
  • Exchange
  • VRAX Nasdaq
  • SLE Nasdaq
  • Market Cap
  • VRAX 2.8M
  • SLE 3.1M
  • IPO Year
  • VRAX 2022
  • SLE 2019
  • Fundamental
  • Price
  • VRAX $0.52
  • SLE $1.17
  • Analyst Decision
  • VRAX Strong Buy
  • SLE Strong Buy
  • Analyst Count
  • VRAX 1
  • SLE 1
  • Target Price
  • VRAX $3.00
  • SLE $80.00
  • AVG Volume (30 Days)
  • VRAX 278.3K
  • SLE 2.4M
  • Earning Date
  • VRAX 01-01-0001
  • SLE 11-13-2025
  • Dividend Yield
  • VRAX N/A
  • SLE N/A
  • EPS Growth
  • VRAX N/A
  • SLE N/A
  • EPS
  • VRAX N/A
  • SLE N/A
  • Revenue
  • VRAX $6,331.00
  • SLE $13,576,000.00
  • Revenue This Year
  • VRAX $217,274.83
  • SLE N/A
  • Revenue Next Year
  • VRAX N/A
  • SLE $28.60
  • P/E Ratio
  • VRAX N/A
  • SLE N/A
  • Revenue Growth
  • VRAX N/A
  • SLE N/A
  • 52 Week Low
  • VRAX $0.52
  • SLE $1.26
  • 52 Week High
  • VRAX $3.20
  • SLE $45.60
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 29.78
  • SLE 32.61
  • Support Level
  • VRAX $0.57
  • SLE $1.34
  • Resistance Level
  • VRAX $0.64
  • SLE $1.55
  • Average True Range (ATR)
  • VRAX 0.04
  • SLE 0.28
  • MACD
  • VRAX -0.01
  • SLE -0.17
  • Stochastic Oscillator
  • VRAX 0.06
  • SLE 0.73

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

Share on Social Networks: